Case Studies

As the probiotic market continues to expand, scientific rigor has become essential to substantiate product claims and ensure regulatory compliance. An international consumer health company required robust evidence from microbiome studies to support the efficacy of its probiotic formulations. Existing studies lacked the depth and resolution needed to clearly demonstrate biological impact, making it difficult to build consumer trust and meet increasingly strict regulatory standards.

Sequentia Biotech provided end-to-end microbiome consulting, combining experimental design expertise with advanced metagenomic analysis. Our integrated approach ensured that every stage of the study—from planning to final reporting—was scientifically sound, reproducible, and aligned with regulatory and publication requirements.